HealthEquity Stock Forecast

Stock Price Forecast

The 12 analysts that cover HealthEquity stock have a consensus rating of "Strong Buy" and an average price target of $117.42, which forecasts a 17.47% increase in the stock price over the next year. The lowest target is $100 and the highest is $130.

Price Target: $117.42 (+17.47%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$100	$117.42	$120	$130
Change	+0.04%	+17.47%	+20.05%	+30.05%

Analyst Ratings

The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	3	4	4	4	4	4
Buy	9	8	7	8	7	7
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	12	13	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
C. Gregory Peters Raymond James	Raymond James	Strong Buy Reiterates $115 → $120	Strong Buy	Reiterates	$115 → $120	+20.05%	Jul 8, 2025
Alexander Paris Barrington Research	Barrington Research	Buy Maintains $112 → $125	Buy	Maintains	$112 → $125	+25.05%	Jun 5, 2025
George Hill Deutsche Bank	Deutsche Bank	Strong Buy Maintains $98 → $115	Strong Buy	Maintains	$98 → $115	+15.05%	Jun 5, 2025
David Roman Goldman Sachs	Goldman Sachs	Hold Maintains $94 → $104	Hold	Maintains	$94 → $104	+4.04%	Jun 4, 2025
Daniel Perlin RBC Capital	RBC Capital	Buy Maintains $112 → $117	Buy	Maintains	$112 → $117	+17.05%	Jun 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.32B

from 1.20B

9.60%

from 1.20B

Revenue Next Year

1.43B

from 1.32B

9.05%

from 1.32B

EPS This Year

3.75

from 1.09

243.59%

from 1.09

EPS Next Year

4.44

from 3.75

18.61%

from 3.75

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Jan 31, 2021	Jan 31, 2022	Jan 31, 2023	Jan 31, 2024	Jan 31, 2025	Jan 31, 2026	Jan 31, 2027	Jan 31, 2028
Revenue	733.57M	756.56M	861.75M	999.59M	1.20B	1.32B	1.43B	1.57B
Revenue Growth	37.89%	3.13%	13.90%	16.00%	20.03%	9.60%	9.05%	9.27%
EPS	0.12	-0.53	-0.31	0.64	1.09	3.75	4.44	5.32
EPS Growth	-79.48%	-	-	-	70.31%	243.59%	18.61%	19.67%
Forward PE	-	-	-	-	-	26.69	22.50	18.81
No. Analysts	-	-	-	-	-	15	13	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	1.4B	1.5B	1.7B
Avg	1.3B	1.4B	1.6B
Low	1.3B	1.4B	1.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	14.3%	16.7%	17.2%
Avg	9.6%	9.0%	9.3%
Low	5.9%	4.0%	3.2%

EPS Forecast

EPS	2026	2027	2028
High	3.97	4.78	5.99
Avg	3.75	4.44	5.32
Low	3.53	4.17	4.89

EPS Growth

EPS Growth	2026	2027	2028
High	264.1%	27.6%	34.7%
Avg	243.6%	18.6%	19.7%
Low	223.7%	11.2%	10.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.